Search Results - "Morscio, J."

EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features by Finalet Ferreiro, J., Morscio, J., Dierickx, D., Vandenberghe, P., Gheysens, O., Verhoef, G., Zamani, M., Tousseyn, T., Wlodarska, I.

“…The molecular pathogenesis of posttransplant diffuse large B cell lymphoma (PT-DLBCL) is largely unknown. We have recently shown that Epstein-Barr…”
Get full text

Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far? by Morscio, J., Tousseyn, T., Dierickx, D.

“…Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disease that arises in 2%–10% of solid organ and hematopoietic stem cell transplants…”
Get full text

Gene Expression Profiling Reveals Clear Differences Between EBV‐Positive and EBV‐Negative Posttransplant Lymphoproliferative Disorders by Morscio, J., Dierickx, D., Ferreiro, J. F., Herreman, A., Van Loo, P., Bittoun, E., Verhoef, G., Matthys, P., Cools, J., Wlodarska, I., De Wolf‐Peeters, C., Sagaert, X., Tousseyn, T.

“…Posttransplant patients are at risk of developing a potentially life‐threatening posttransplantation lymphoproliferative disorder (PTLD), most often of diffuse…”
Get full text

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern by Ferreiro, Julio Finalet, Morscio, Julie, Dierickx, Daan, Marcelis, Lukas, Verhoef, Gregor, Vandenberghe, Peter, Tousseyn, Thomas, Wlodarska, Iwona

Get full text

New insights in the molecular pathogenesis of Epstein–Barr virus-positive and -negative post-transplant diffuse large B-cell lymphoma by Morscio, J, Ferreiro, J. Finalet, Dierickx, D, Verhoef, G, Wlodarska, I, Tousseyn, T

Get full text

The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder by Dierickx, Daan, Tousseyn, Thomas, Requilé, Annelies, Verscuren, Raf, Sagaert, Xavier, Morscio, Julie, Wlodarska, Iwona, Herreman, An, Kuypers, Dirk, Van Cleemput, Johan, Nevens, Frederik, Dupont, Lieven, Uyttebroeck, Anne, Pirenne, Jacques, De Wolf-Peeters, Christiane, Verhoef, Gregor, Brepoels, Lieselot, Gheysens, Olivier

“…We investigated sensitivity, specificity, positive predictive value, negative predictive value and accuracy of 18F-fluorodeoxyglucose-positron emission…”
Get full text

823 - New insights in the molecular pathogenesis of Epstein–Barr virus-positive and -negative post-transplant diffuse large B-cell lymphoma by Morscio, J., Ferreiro, J. Finalet, Dierickx, D., Verhoef, G., Wlodarska, I., Tousseyn, T.

Get full text

PF157 THERAPEUTIC TARGETING OF CYTOKINE INDUCED PIM1 ACTIVATION IN T‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA by De Smedt, R., Peirs, S., Van Trimpont, M., Morscio, J., Roels, J., Reunes, L., Lintermans, B., Lammens, T., Van Roy, N., De Moerloose, B., Benoit, Y., Meijerink, J.P., Goossens, S., Van Vlierberghe, P.

“…Background: PIM1 is an oncogenic kinase that recently emerged as an interesting novel therapeutic target for the treatment of T‐cell acute lymphoblastic…”
Get full text

Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder : What Do We Know So Far? by Morscio, J., Tousseyn, T., Dierickx, D.

“…Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal disease that arises in 2%–10% of solid organ and hematopoietic stem cell transplants…”
Get full text